In summary, the oral administration of RP and IRP 1–4 markedly ameliorated hyperglycemia in the T2DM mice, characterized by a decrease in the food and water intake, FBG, and enhanced glucose tolerance. The gene discussed is WNT2; the disease is glucose measurement.